|
🐜
|
Drug-eluting versus bare-metal stents in large coronary arteries.
14 auth.
C. Kaiser,
S. Galatius,
P. Erne,
F. Eberli,
H. Alber,
H. Rickli,
G. Pedrazzini,
B. Hornig,
O. Bertel,
P. Bonetti,
...
S. de Servi,
H. Brunner-la Rocca,
Ingrid Ricard,
M. Pfisterer
|
8 |
2010 |
8
🐜
|
|
🐜
|
Second Internal Thoracic Artery Versus Radial Artery in Coronary Artery Bypass Grafting: A Long-Term, Propensity Score–Matched Follow-Up Study
8 auth.
E. Ruttmann,
N. Fischler,
A. Šakić,
O. Chevtchik,
H. Alber,
R. Schistek,
...
H. Ulmer,
M. Grimm
|
6 |
2011 |
6
🐜
|
|
🐜
|
Long-term efficacy and safety of biodegradable-polymer biolimus-eluting stents: main results of the Basel Stent Kosten-Effektivitäts Trial-PROspective Validation Examination II (BASKET-PROVE II), a randomized, controlled noninferiority 2-year outcome trial.
25 auth.
C. Kaiser,
S. Galatius,
R. Jeger,
N. Gilgen,
J. Skov Jensen,
C. Naber,
H. Alber,
M. Wanitschek,
F. Eberli,
D. Kurz,
G. Pedrazzini,
T. Moccetti,
H. Rickli,
D. Weilenmann,
A. Vuillomenet,
...
Martin Steiner,
S. von Felten,
D. Vogt,
K. Wadt Hansen,
P. Rickenbacher,
D. Conen,
C. Müller,
P. Buser,
A. Hoffmann,
M. Pfisterer
|
6 |
2015 |
6
🐜
|
|
🐜
|
Discontinuation versus continuation of renin-angiotensin-system inhibitors in COVID-19 (ACEI-COVID): a prospective, parallel group, randomised, controlled, open-label trial
114 auth.
A. Bauer,
M. Schreinlechner,
N. Sappler,
T. Dolejsi,
H. Tilg,
B. Aulinger,
G. Weiss,
R. Bellmann-Weiler,
C. Adolf,
Dominik J. Wolf,
M. Pirklbauer,
I. Graziadei,
Hannes Gänzer,
C. von Bary,
A. May,
...
E. Wöll,
W. von Scheidt,
T. Rassaf,
D. Duerschmied,
C. Brenner,
S. Kääb,
B. Metzler,
M. Joannidis,
Hans-Ulrich Kain,
Norbert Kaiser,
R. Schwinger,
B. Witzenbichler,
H. Alber,
F. Straube,
N. Hartmann,
S. Achenbach,
M. von Bergwelt-Baildon,
Lukas von Stülpnagel,
S. Schoenherr,
L. Forer,
Sabine Embacher-Aichhorn,
U. Mansmann,
K. Rizas,
S. Massberg,
Marcin Bantkowiak,
Gabriele Baur,
Monika Baylacher,
Marcel Beaucamp,
M. Berger,
L. Besch,
S. Brunner,
S. Budweiser,
H. Bugger,
R. Coletti,
U. Dorwarth,
J. Egresits,
Elodie Eiffener,
C. Faul,
A. Finkenstedt,
Konstantinos Gatos,
Nadine Gauchel,
F. Gindele,
W. Grander,
Markus Gunschl,
F. Hartig,
M. Hecht,
T. Heer,
L. Heger,
M. Hentrich,
L. Horvath,
D. Keta,
S. Kiechl,
R. Kirchmaier,
Andreas Klein,
M. Klemm,
E. Kolesnik,
A. König,
H. Kossmann,
J. Kropáček,
L. Lanser,
A. Lother,
A. Löw,
A. Mahabadi,
S. Malleier,
G. Mayer,
C. Müller,
D. Müller-Wieland,
B. Nagel,
H. Neuwirt,
C. Olivier,
T. Raunegger,
M. Reindl,
S. Reinstadler,
L. Riesinger,
M. Schäffner,
John E. Schier,
J. Schock,
Peter Schönherr,
M. Schulz,
Thomas Schütz,
Johannes Schwarz,
J. Siebermair,
M. Siry,
Anna Spaur,
W. Sturm,
Kristin Tessadri,
F. Theurl,
M. Theurl,
Liz Thommes,
C. Tiller,
M. Toifl,
M. Totzeck,
Hedda von zur Mühlen,
N. Vonderlin,
R. Wakili,
C. Wendtner,
F. Wenner,
D. Wimmert-Roidl,
A. Zabernigg
|
6 |
2021 |
6
🐜
|
|
🐜
|
The prevalence of cirrhotic cardiomyopathy according to different diagnostic criteria
7 auth.
M. Razpotnik,
S. Bota,
P. Wimmer,
M. Hackl,
G. Lesnik,
H. Alber,
...
M. Peck‐Radosavljevic
|
5 |
2020 |
5
🐜
|
|
🐜
|
CYP2C19 Phenoconversion by Routinely Prescribed Proton Pump Inhibitors Omeprazole and Esomeprazole: Clinical Implications for Personalized Medicine
8 auth.
M. Klieber,
H. Oberacher,
Silvia Hofstaetter,
B. Beer,
Martin Neururer,
A. Amann,
...
H. Alber,
A. Modak
|
4 |
2015 |
4
🐜
|
|
🐜
|
Heart rate at discharge and long-term prognosis following percutaneous coronary intervention in stable and acute coronary syndromes--results from the BASKET PROVE trial.
17 auth.
M. Jensen,
C. Kaiser,
Karl Erik Sandsten,
H. Alber,
M. Wanitschek,
A. Iversen,
J. Jensen,
S. Pedersen,
R. Soerensen,
H. Rickli,
...
M. Żurek,
G. Fahrni,
O. Bertel,
S. de Servi,
P. Erne,
M. Pfisterer,
S. Galatius
|
4 |
2013 |
4
🐜
|
|
🐜
|
Impact of stent diameter and length on in‐stent restenosis after DES vs BMS implantation in patients needing large coronary stents—A clinical and health‐economic evaluation
12 auth.
R. Zbinden,
S. von Felten,
B. Wein,
D. Tueller,
D. Kurz,
I. Reho,
...
S. Galatius,
H. Alber,
D. Conen,
M. Pfisterer,
C. Kaiser,
F. Eberli
|
4 |
2017 |
4
🐜
|
|
🐜
|
Newest-generation drug-eluting and bare-metal stents combined with prasugrel-based antiplatelet therapy in large coronary arteries: the BAsel Stent Kosten Effektivitäts Trial PROspective Validation Examination part II (BASKET-PROVE II) trial design.
12 auth.
R. Jeger,
M. Pfisterer,
H. Alber,
F. Eberli,
S. Galatius,
C. Naber,
...
G. Pedrazzini,
H. Rickli,
J. Jensen,
A. Vuilliomenet,
N. Gilgen,
C. Kaiser
|
4 |
2012 |
4
🐜
|
